I en undersøgelse foretaget på patienter med moderat nedsat leverfunktion (Child- Pugh- score 7- 9) adskilte farmakokinetikken for micafungin sig ikke signifikant fra den hos raske forsøgspersoner (n=8).
In a study performed in patients with moderate hepatic impairment (Child-Pugh score 7-9), (n=8), the pharmacokinetics of micafungin did not significantly differ from those in healthy subjects (n=8).